07/30/2014 - 2:34pm

Pfizer on Wednesday announced that it has entered into a definitive agreement to acquire Baxter International’s portfolio of marketed vaccines for $635 million.

07/30/2014 - 10:32am

GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.

07/28/2014 - 1:41pm

Reckitt Benckiser announced the company will be looking to spin off its pharma business in the next 12 months. 

 

07/28/2014 - 12:58pm

The Food and Drug Administration on Monday expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.

07/24/2014 - 12:19pm

The Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), a long-acting opioid analgesic.

07/24/2014 - 12:03pm

Onco360, an independent oncology pharmacy and clinical support services company, announced that it has been selected to be part of the highly limited specialty pharmacy network of Zydelig tablets.

07/23/2014 - 3:05pm

The first batch of vaccines for the upcoming flu season is on its way to pharmacies, hospitals and doctors offices.

07/21/2014 - 10:48am

Innocutis on Monday announced the introduction of Sitavig (acyclovir) 50-mg buccal tablet into North American markets.

07/21/2014 - 10:08am

Sandoz on Monday announced an agreement with Anacor Pharmaceuticals to obtain exclusive rights to commercialize Kerydin (tavaborole) topical solution, 5%, through its branded dermatology business, PharmaDerm.